Centre for Cognitive and Neural Systems, Edinburgh Neuroscience, The University of Edinburgh, 1 George Square, Edinburgh EH8 9JZ, UK.
Neuropharmacology. 2013 Nov;74:32-40. doi: 10.1016/j.neuropharm.2013.04.014. Epub 2013 Apr 27.
It is humbling to think that 30 years have passed since the paper by Collingridge, Kehl and McLennan showing that one of Jeff Watkins most interesting compounds, R-2-amino-5-phosphonopentanoate (d-AP5), blocked the induction of long-term potentiation in vitro at synapses from area CA3 of the hippocampus to CA1 without apparent effect on baseline synaptic transmission (Collingridge et al., 1983). This dissociation was one of the key triggers for an explosion of interest in glutamate receptors, and much has been discovered since that collectively contributes to our contemporary understanding of glutamatergic synapses - their biophysics and subunit composition, of the agonists and antagonists acting on them, and their diverse functions in different networks of the brain and spinal cord. It can be fairly said that Collingridge et al.'s (1983) observation was the stimulus that has led, on the one hand, to structural biological work at the atomic scale describing the key features of NMDA receptors that enables their coincidence function to happen; and, on the other, to work with whole animals investigating the contributions that calcium signalling via this receptor can have on rhythmical activities controlled by spinal circuits, memory encoding in the hippocampus (the topic of this article), visual cortical plasticity, sensitization in pain, and other functions. In this article, I lay out how my then interest in long-term potentiation (LTP) as a model of memory enabled me to recognise the importance of Collingridge et al.'s discovery - and how I and my colleagues endeavoured to take things forward in the area of learning and memory. This is in some respects a personal story, and I tell it as such. The idea that NMDA receptor activation is essential for memory encoding, though not for storage, took time to develop and to be accepted. Along the way, there have been confusions, challenges, and surprises surrounding the idea that activation of NMDA receptors can trigger memory. Some of these are described and how they have been addressed and resolved. Last, I touch on some new directions of interest with respect to the functional role of the NMDA receptor in cognition. This article is part of the Special Issue entitled 'Glutamate Receptor-Dependent Synaptic Plasticity'.
令人感到谦卑的是,自从科林里奇、凯尔和麦克伦南发表的论文指出杰夫·沃特金斯(Jeff Watkins)最有趣的化合物之一——R-2-氨基-5-磷戊酸酯(d-AP5)——在没有明显影响基础突触传递的情况下,能够阻断体外海马 CA3 区到 CA1 区突触的长时程增强诱导以来,已经过去了 30 年。这种分离是谷氨酸受体研究兴趣爆炸的关键触发因素之一,自那时以来,许多发现共同促进了我们对谷氨酸能突触的当代理解——它们的生物物理学和亚基组成、作用于它们的激动剂和拮抗剂,以及它们在大脑和脊髓不同网络中的多种功能。可以说,科林里奇等人(1983 年)的观察结果是导致一方面在原子尺度上进行结构生物学工作的刺激,描述了 NMDA 受体的关键特征,使其能够发生协同功能;另一方面,使用整个动物来研究通过该受体的钙信号传导对脊髓电路控制的节律活动、海马体(本文主题)中的记忆编码、视皮层可塑性、疼痛敏化和其他功能的贡献。在本文中,我阐述了我对长时程增强(LTP)作为记忆模型的兴趣如何使我认识到科林里奇等人发现的重要性——以及我和我的同事们如何努力在学习和记忆领域取得进展。从某种程度上说,这是一个个人故事,我就这样讲述了。尽管 NMDA 受体的激活对于存储不是必需的,但对于记忆编码是必需的,这一观点需要时间来发展和被接受。在此过程中,围绕 NMDA 受体激活可以触发记忆的观点存在混淆、挑战和惊喜。其中一些被描述出来,以及它们是如何被解决的。最后,我提到了一些关于 NMDA 受体在认知中的功能作用的新的研究方向。本文是题为“谷氨酸受体依赖性突触可塑性”的特刊的一部分。